Lindsay Raymer
Psychiatry · Houston, TXNPI 1528221355
Payments from drug & device makers
Across 115 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$536
- Johnson & Johnson$326
- Lundbeck LLC$157
- Shire North American Group Inc$155
- Neurocrine Biosciences, Inc.$148
- Takeda Pharmaceuticals U.S.A., Inc.$106
- plus $624 from 13 others
What the payments were for
- Food & beverage$2,051100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 28 | $536 |
| Johnson & Johnson | 18 | $326 |
| Lundbeck LLC | 11 | $157 |
| Shire North American Group Inc | 9 | $155 |
| Neurocrine Biosciences, Inc. | 7 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $106 |
| AbbVie | 6 | $94 |
| Bausch Health US, LLC | 4 | $83 |
| Ironshore Pharmaceuticals Inc. | 4 | $75 |
| Jazz Pharmaceuticals Inc. | 3 | $69 |
| Sunovion Pharmaceuticals Inc. | 3 | $56 |
| Neos Therapeutics, LP | 4 | $55 |
| Tris Pharma Inc | 3 | $50 |
| Adlon Therapeutics L.p. | 2 | $37 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Alkermes, Inc. | 1 | $24 |
| OWP Pharmaceuticals, Inc. | 1 | $19 |
| Validus Pharmaceuticals LLC | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$2,051 in reported general payments places this provider in the 75th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 21 | $974 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 15 | $871 |
| Gabapentin | 18 | $758 |
| Escitalopram Oxalate | 58 | $632 |
| Bupropion XlBupropion Hcl | 17 | $605 |
| Lurasidone Hcl | 12 | $417 |
| Clonazepam | 55 | $405 |
| Lamotrigine | 23 | $359 |
| Temazepam | 22 | $345 |
| Fluoxetine Hcl | 17 | $294 |
| Quetiapine Fumarate | 18 | $254 |
| Trazodone Hcl | 22 | $254 |
| Doxepin Hcl | 21 | $243 |
| Lithium Carbonate | 12 | $164 |
| Alprazolam | 35 | $126 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Houston
- Matthew BramsHouston$3M
- Lawrence GinsbergHouston$2.4M
- Asim ShahHouston$2.2M
- Aqeel HashmiHouston$1.3M
- Robert EarleHouston$1.1M
- Frank ChenHouston$941K
- Joao de QuevedoHouston$890K
- Alice MaoHouston$850K
- Mazhar KhowajaHouston$843K
- Barry GritzHouston$792K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.